
<p>Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy</p>
Author(s) -
Yiyi Zhang,
Meifang Xu,
Jianhua Chen,
Kui Chen,
Jinfu Zhuang,
Yuanfeng Yang,
Xing Liu,
Guoxian Guan
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s255956
Subject(s) - medicine , colorectal cancer , pathological , oncology , chemoradiotherapy , biomarker , proportional hazards model , immunohistochemistry , stage (stratigraphy) , multivariate analysis , cancer , neoadjuvant therapy , gastroenterology , paleontology , biochemistry , breast cancer , biology , chemistry
To assess the role of the expression levels of FOXK family members, FOXK1 and FOXK2, in predicting response to neo-chemoradiotherapy (NCRT) and prognosis in locally advanced rectal cancer (LARC).